Saturday, December 13, 2025 | 06:53 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Will explore more investments if incentivised by the govt: Medtronic

Atmanirbharta can be achieved when design and development in India are part of the plan, said the company

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
premium

Madan Krishnan, vice president and managing director, Medtronic India said that R&D leads to innovation which is crucial to growth strategy

TE Narasimhan Chennai
Medtronic plc, medical technology global major, recently announced Rs 1,200 crore investment in India. The company has said that it would explore more investment opportunities, including in manufacturing, if the government offers incentives and addresses other challenges. The development comes at a time the government is trying to attract investments in various sectors under Atmanirbhar Bharat (self-reliant India).

Madan Krishnan, vice president and managing director, Medtronic India said that R&D leads to innovation which is crucial to growth strategy. The Rs 1,200 crore in scaling up and expanding Medtronic Engineering & Innovation Center in Hyderabad into an engineering and innovation center